Results 21 to 30 of about 62,795 (319)
Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera. [PDF]
We describe the course and likely pathophysiology of impending anterior ischemic optic neuropathy (AION) and retinal vein occlusion in a 56-year-old man with polycythemia vera managed with interferon alpha for 2 years.
Hirsch, Louis K+2 more
core +1 more source
Polycythemia vera: myths, mechanisms, and management.
Polycythemia vera is a clonal disorder arising in a multipotent hematopoietic progenitor cell that causes the accumulation of morphologically normal red cells, white cells, platelets, and their progenitors in the absence of a definable stimulus and to ...
J. Spivak
semanticscholar +1 more source
Polycythemia: A Clinical Approach
Polycythemia or erythrocytosis is an increase in the number of red blood cells in circulation marked by the increase in hematocrit. Polycythemia is a case that still raises questions and dilemma for doctors.
Rahmat Cahyanur, Ikhwan Rinaldi
doaj +1 more source
Background Studies describing the clinical progression of animals with reverse patent ductus arteriosus (PDA) are lacking. Objectives To describe the signalment, presenting signs, echocardiographic features, and survival in a group of dogs and cats with ...
Victoria Greet+5 more
doaj +1 more source
Aberrant expression of microRNA in polycythemia vera
Background Polycythemia vera is a clonal hematopoietic stem cell disorder in which the JAK2 V617F mutation is observed in >95% of patients, but an as yet unidentified process appears to initiate the clonal expansion of hematopoiesis.
Hana Bruchova+2 more
doaj +1 more source
Association of subcutaneous testosterone pellet therapy with developing secondary polycythemia
A variety of methods for testosterone replacement therapy (TRT) exist, and the major potential risks of TRT have been well established. The risk of developing polycythemia secondary to exogenous testosterone (T) has been reported to range from 0.4% to 40%
Katherine Lang Rotker+6 more
doaj +1 more source
Feline primary erythrocytosis: a multicentre case series of 18 cats [PDF]
A retrospective multicentre case series of feline primary erythrocytosis (PE) was evaluated. The aim was to gain better understanding of disease presentation and progression to guide management and prognostication. Case records were assessed for evidence
Balazs Szladovits+7 more
core +1 more source
Consensus diagnostic criteria and monitoring of twin anemia–polycythemia sequence: Delphi procedure
Twin anemia–polycythemia sequence (TAPS) is associated with increased perinatal morbidity and mortality. Inconsistencies in the diagnostic criteria for TAPS exist, which hinder the ability to establish robust evidence‐based management or monitoring ...
A. Khalil+11 more
semanticscholar +1 more source
Extent of hematopoietic involvement by TET2 mutations in JAK2V617F polycythemia vera
TET2 mutations are found in polycythemia vera and it was initially reported that there is a greater TET2 mutational burden than JAK2V617F in polycythemia vera stem cells and that TET2 mutations precede JAK2V617F.
Sabina I. Swierczek+7 more
doaj +1 more source